TransCelerate’s Clinical Quality Management System: From a Vision to a Conceptual Framework

The Quality Management System (QMS) initiative of TransCelerate BioPharma Inc has identified potential benefits that could be captured from the development of a flexible, proactive clinical QMS conceptual framework for clinical research. Such a framework would aid organizations in seamlessly managin...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic innovation & regulatory science 2016-07, Vol.50 (4), p.397-413
Main Authors: Meeker-O’Connell, Ann, Sam, Leslie M., Bergamo, Nanci, Little, Janis A.
Format: Article
Language:English
Subjects:
Authorship
Clinical trials
Collaboration
Compliance
Decision making
Design
Drug Safety and Pharmacovigilance
Feedback
Good Manufacturing Practice
Knowledge management
Patient safety
Patients
Pharmaceutical industry
Pharmacotherapy
Pharmacy
Quality management
R&D
Research & development
Risk assessment
Sponsored Special Section by TransCelerate BioPharma: Analytical Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c482t-d14c274128acff32723eb258ef987ef54d574d82c1918614c22fc15fa50e83f63
cites cdi_FETCH-LOGICAL-c482t-d14c274128acff32723eb258ef987ef54d574d82c1918614c22fc15fa50e83f63
container_end_page 413
container_issue 4
container_start_page 397
container_title Therapeutic innovation & regulatory science
container_volume 50
creator Meeker-O’Connell, Ann
Sam, Leslie M.
Bergamo, Nanci
Little, Janis A.
description The Quality Management System (QMS) initiative of TransCelerate BioPharma Inc has identified potential benefits that could be captured from the development of a flexible, proactive clinical QMS conceptual framework for clinical research. Such a framework would aid organizations in seamlessly managing the complex clinical trial environment and, ultimately, in expediting delivery of needed treatments to patients. This article chronicles the evolution of a TransCelerate concept paper describing a proposed clinical QMS framework and reviews feedback from varied global clinical trial stakeholders during socialization of the concept paper. Many stakeholders recognized the potential for the concept paper to inform development of a harmonized International Council for Harmonisation (ICH) guideline, providing needed clarity from regulators on their expectations for QMS in the clinical realm. Accordingly, the article also describes TransCelerate’s efforts to work with regulators to facilitate harmonization on this important topic and reviews ongoing work to develop additional tools and resources that may support organizations in evaluating whether and how they might translate the conceptual framework principles into practice.
doi_str_mv 10.1177/2168479016651300
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179219837</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2168479016651300</sage_id><sourcerecordid>2179219837</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-d14c274128acff32723eb258ef987ef54d574d82c1918614c22fc15fa50e83f63</originalsourceid><addsrcrecordid>eNqNkc1KAzEUhYMottTuXcmAGzejyZ1kkllK8Q8qItb1kM7clCnzU5OZRXe-hq_nk5ihrUhBNJsbcr9zLjmXkFNGLxmT8gpYrLhMKItjwSJKD8iwfwq5ovxwd_f9ARk7t6T-JEpIUMdkEFEASUEMCZ9ZXbsJlmh1i5_vHy6YlEVdZLoMnjtdFu06eNS1XmCFdRu8rF2L1Qk5Mrp0ON7WEXm9vZlN7sPp093D5HoaZlxBG-aMZyA5A6UzYyKQEOEchEKTKIlG8FxInivIWMJU3MNgMiaMFhRVZOJoRC42vivbvHXo2rQqXIZlqWtsOpcCkwmwREXyT5QpqmIABcqj53vosuls7T_SUz49EUeJp-iGymzjnEWTrmxRabtOGU37_NP9_L3kbGvczSvMvwW7tD3ANoDzrXqB9sfk303Drcbv4B_8F2SomP4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1804805639</pqid></control><display><type>article</type><title>TransCelerate’s Clinical Quality Management System: From a Vision to a Conceptual Framework</title><source>Springer Link</source><creator>Meeker-O’Connell, Ann ; Sam, Leslie M. ; Bergamo, Nanci ; Little, Janis A.</creator><creatorcontrib>Meeker-O’Connell, Ann ; Sam, Leslie M. ; Bergamo, Nanci ; Little, Janis A.</creatorcontrib><description>The Quality Management System (QMS) initiative of TransCelerate BioPharma Inc has identified potential benefits that could be captured from the development of a flexible, proactive clinical QMS conceptual framework for clinical research. Such a framework would aid organizations in seamlessly managing the complex clinical trial environment and, ultimately, in expediting delivery of needed treatments to patients. This article chronicles the evolution of a TransCelerate concept paper describing a proposed clinical QMS framework and reviews feedback from varied global clinical trial stakeholders during socialization of the concept paper. Many stakeholders recognized the potential for the concept paper to inform development of a harmonized International Council for Harmonisation (ICH) guideline, providing needed clarity from regulators on their expectations for QMS in the clinical realm. Accordingly, the article also describes TransCelerate’s efforts to work with regulators to facilitate harmonization on this important topic and reviews ongoing work to develop additional tools and resources that may support organizations in evaluating whether and how they might translate the conceptual framework principles into practice.</description><identifier>ISSN: 2168-4790</identifier><identifier>EISSN: 2168-4804</identifier><identifier>DOI: 10.1177/2168479016651300</identifier><identifier>PMID: 30227025</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Authorship ; Clinical trials ; Collaboration ; Compliance ; Decision making ; Design ; Drug Safety and Pharmacovigilance ; Feedback ; Good Manufacturing Practice ; Knowledge management ; Patient safety ; Patients ; Pharmaceutical industry ; Pharmacotherapy ; Pharmacy ; Quality management ; R&amp;D ; Research &amp; development ; Risk assessment ; Sponsored Special Section by TransCelerate BioPharma: Analytical Report</subject><ispartof>Therapeutic innovation &amp; regulatory science, 2016-07, Vol.50 (4), p.397-413</ispartof><rights>The Author(s) 2016</rights><rights>Drug Information Association, Inc 2016</rights><rights>Copyright Drug Information Association Jul 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-d14c274128acff32723eb258ef987ef54d574d82c1918614c22fc15fa50e83f63</citedby><cites>FETCH-LOGICAL-c482t-d14c274128acff32723eb258ef987ef54d574d82c1918614c22fc15fa50e83f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30227025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meeker-O’Connell, Ann</creatorcontrib><creatorcontrib>Sam, Leslie M.</creatorcontrib><creatorcontrib>Bergamo, Nanci</creatorcontrib><creatorcontrib>Little, Janis A.</creatorcontrib><title>TransCelerate’s Clinical Quality Management System: From a Vision to a Conceptual Framework</title><title>Therapeutic innovation &amp; regulatory science</title><addtitle>Ther Innov Regul Sci</addtitle><addtitle>Ther Innov Regul Sci</addtitle><description>The Quality Management System (QMS) initiative of TransCelerate BioPharma Inc has identified potential benefits that could be captured from the development of a flexible, proactive clinical QMS conceptual framework for clinical research. Such a framework would aid organizations in seamlessly managing the complex clinical trial environment and, ultimately, in expediting delivery of needed treatments to patients. This article chronicles the evolution of a TransCelerate concept paper describing a proposed clinical QMS framework and reviews feedback from varied global clinical trial stakeholders during socialization of the concept paper. Many stakeholders recognized the potential for the concept paper to inform development of a harmonized International Council for Harmonisation (ICH) guideline, providing needed clarity from regulators on their expectations for QMS in the clinical realm. Accordingly, the article also describes TransCelerate’s efforts to work with regulators to facilitate harmonization on this important topic and reviews ongoing work to develop additional tools and resources that may support organizations in evaluating whether and how they might translate the conceptual framework principles into practice.</description><subject>Authorship</subject><subject>Clinical trials</subject><subject>Collaboration</subject><subject>Compliance</subject><subject>Decision making</subject><subject>Design</subject><subject>Drug Safety and Pharmacovigilance</subject><subject>Feedback</subject><subject>Good Manufacturing Practice</subject><subject>Knowledge management</subject><subject>Patient safety</subject><subject>Patients</subject><subject>Pharmaceutical industry</subject><subject>Pharmacotherapy</subject><subject>Pharmacy</subject><subject>Quality management</subject><subject>R&amp;D</subject><subject>Research &amp; development</subject><subject>Risk assessment</subject><subject>Sponsored Special Section by TransCelerate BioPharma: Analytical Report</subject><issn>2168-4790</issn><issn>2168-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkc1KAzEUhYMottTuXcmAGzejyZ1kkllK8Q8qItb1kM7clCnzU5OZRXe-hq_nk5ihrUhBNJsbcr9zLjmXkFNGLxmT8gpYrLhMKItjwSJKD8iwfwq5ovxwd_f9ARk7t6T-JEpIUMdkEFEASUEMCZ9ZXbsJlmh1i5_vHy6YlEVdZLoMnjtdFu06eNS1XmCFdRu8rF2L1Qk5Mrp0ON7WEXm9vZlN7sPp093D5HoaZlxBG-aMZyA5A6UzYyKQEOEchEKTKIlG8FxInivIWMJU3MNgMiaMFhRVZOJoRC42vivbvHXo2rQqXIZlqWtsOpcCkwmwREXyT5QpqmIABcqj53vosuls7T_SUz49EUeJp-iGymzjnEWTrmxRabtOGU37_NP9_L3kbGvczSvMvwW7tD3ANoDzrXqB9sfk303Drcbv4B_8F2SomP4</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Meeker-O’Connell, Ann</creator><creator>Sam, Leslie M.</creator><creator>Bergamo, Nanci</creator><creator>Little, Janis A.</creator><general>SAGE Publications</general><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20160701</creationdate><title>TransCelerate’s Clinical Quality Management System</title><author>Meeker-O’Connell, Ann ; Sam, Leslie M. ; Bergamo, Nanci ; Little, Janis A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-d14c274128acff32723eb258ef987ef54d574d82c1918614c22fc15fa50e83f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Authorship</topic><topic>Clinical trials</topic><topic>Collaboration</topic><topic>Compliance</topic><topic>Decision making</topic><topic>Design</topic><topic>Drug Safety and Pharmacovigilance</topic><topic>Feedback</topic><topic>Good Manufacturing Practice</topic><topic>Knowledge management</topic><topic>Patient safety</topic><topic>Patients</topic><topic>Pharmaceutical industry</topic><topic>Pharmacotherapy</topic><topic>Pharmacy</topic><topic>Quality management</topic><topic>R&amp;D</topic><topic>Research &amp; development</topic><topic>Risk assessment</topic><topic>Sponsored Special Section by TransCelerate BioPharma: Analytical Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meeker-O’Connell, Ann</creatorcontrib><creatorcontrib>Sam, Leslie M.</creatorcontrib><creatorcontrib>Bergamo, Nanci</creatorcontrib><creatorcontrib>Little, Janis A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Toxicology Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Proquest Research Library</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic innovation &amp; regulatory science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meeker-O’Connell, Ann</au><au>Sam, Leslie M.</au><au>Bergamo, Nanci</au><au>Little, Janis A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TransCelerate’s Clinical Quality Management System: From a Vision to a Conceptual Framework</atitle><jtitle>Therapeutic innovation &amp; regulatory science</jtitle><stitle>Ther Innov Regul Sci</stitle><addtitle>Ther Innov Regul Sci</addtitle><date>2016-07-01</date><risdate>2016</risdate><volume>50</volume><issue>4</issue><spage>397</spage><epage>413</epage><pages>397-413</pages><issn>2168-4790</issn><eissn>2168-4804</eissn><abstract>The Quality Management System (QMS) initiative of TransCelerate BioPharma Inc has identified potential benefits that could be captured from the development of a flexible, proactive clinical QMS conceptual framework for clinical research. Such a framework would aid organizations in seamlessly managing the complex clinical trial environment and, ultimately, in expediting delivery of needed treatments to patients. This article chronicles the evolution of a TransCelerate concept paper describing a proposed clinical QMS framework and reviews feedback from varied global clinical trial stakeholders during socialization of the concept paper. Many stakeholders recognized the potential for the concept paper to inform development of a harmonized International Council for Harmonisation (ICH) guideline, providing needed clarity from regulators on their expectations for QMS in the clinical realm. Accordingly, the article also describes TransCelerate’s efforts to work with regulators to facilitate harmonization on this important topic and reviews ongoing work to develop additional tools and resources that may support organizations in evaluating whether and how they might translate the conceptual framework principles into practice.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>30227025</pmid><doi>10.1177/2168479016651300</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-4790
ispartof Therapeutic innovation & regulatory science, 2016-07, Vol.50 (4), p.397-413
issn 2168-4790
2168-4804
language eng
recordid cdi_proquest_miscellaneous_2179219837
source Springer Link
subjects Authorship
Clinical trials
Collaboration
Compliance
Decision making
Design
Drug Safety and Pharmacovigilance
Feedback
Good Manufacturing Practice
Knowledge management
Patient safety
Patients
Pharmaceutical industry
Pharmacotherapy
Pharmacy
Quality management
R&D
Research & development
Risk assessment
Sponsored Special Section by TransCelerate BioPharma: Analytical Report
title TransCelerate’s Clinical Quality Management System: From a Vision to a Conceptual Framework
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T04%3A07%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TransCelerate%E2%80%99s%20Clinical%20Quality%20Management%20System:%20From%20a%20Vision%20to%20a%20Conceptual%20Framework&rft.jtitle=Therapeutic%20innovation%20&%20regulatory%20science&rft.au=Meeker-O%E2%80%99Connell,%20Ann&rft.date=2016-07-01&rft.volume=50&rft.issue=4&rft.spage=397&rft.epage=413&rft.pages=397-413&rft.issn=2168-4790&rft.eissn=2168-4804&rft_id=info:doi/10.1177/2168479016651300&rft_dat=%3Cproquest_cross%3E2179219837%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c482t-d14c274128acff32723eb258ef987ef54d574d82c1918614c22fc15fa50e83f63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1804805639&rft_id=info:pmid/30227025&rft_sage_id=10.1177_2168479016651300&rfr_iscdi=true